Proteins lead the way: JAK inhibitors as a new treatment option in toxic epidermal necrolysis
Saved in:
Main Authors: | Benjamin Klein, J. Michelle Kahlenberg, Johann E. Gudjonsson |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2025-02-01
|
Series: | Signal Transduction and Targeted Therapy |
Online Access: | https://doi.org/10.1038/s41392-024-02122-6 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
by: Jeanneth Elizabeth Jami Carrera, et al.
Published: (2024-11-01) -
Topical Ophthalmic Cyclosporine in the Treatment of Toxic Epidermal Necrolysis
by: Zafer Onaran, et al.
Published: (2011-01-01) -
Intensive Care in a Patient with Toxic Epidermal Necrolysis
by: J. Wallenborn, et al.
Published: (2017-01-01) -
Toxic Epidermal Necrolysis after COVID-19 mRNA-1237 Vaccination
by: Nicole Hehr, et al.
Published: (2023-01-01) -
The Epidemiology of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in China
by: Shang-Chen Yang, et al.
Published: (2018-01-01)